Elucidating the connectionsbetween DBC1, HDAC3 and Rev-erbs may have implications for the pathogenesis and treatment ofmetabolic diseases such as obesity, diabetes, liver steatosis and metabolic syndrome. This evidence concerns the gene CCAR2 and diabetes mellitus.